Trial Results Support SBRT as a Standard Option for Some Prostate Cancers

🔗 Access full article via NCI Cancer Currents

In a trial, men who received stereotactic body radiotherapy (SBRT) didn’t have a higher risk of cancer recurrence than men treated with other common radiation therapy regimens that are given over longer periods.